| UniProt ID | COG3_HUMAN | |
|---|---|---|
| UniProt AC | Q96JB2 | |
| Protein Name | Conserved oligomeric Golgi complex subunit 3 | |
| Gene Name | COG3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 828 | |
| Subcellular Localization |
Golgi apparatus, Golgi stack membrane Peripheral membrane protein . Associated with the peripheral membrane of cis/medial cisternae. |
|
| Protein Description | Involved in ER-Golgi transport.. | |
| Protein Sequence | MAEAALLLLPEAAAERDAREKLALWDRRPDTTAPLTDRQTDSVLELKAAAENLPVPAELPIEDLCSLTSQSLPIELTSVVPESTEDILLKGFTSLGMEEERIETAQQFFSWFAKLQTQMDQDEGTKYRQMRDYLSGFQEQCDAILNDVNSALQHLESLQKQYLFVSNKTGTLHEACEQLLKEQSELVDLAENIQQKLSYFNELETINTKLNSPTLSVNSDGFIPMLAKLDDCITYISSHPNFKDYPIYLLKFKQCLSKALHLMKTYTVNTLQTLTSQLLKRDPSSVPNADNAFTLFYVKFRAAAPKVRTLIEQIELRSEKIPEYQQLLNDIHQCYLDQRELLLGPSIACTVAELTSQNNRDHCALVRSGCAFMVHVCQDEHQLYNEFFTKPTSKLDELLEKLCVSLYDVFRPLIIHVIHLETLSELCGILKNEVLEDHVQNNAEQLGAFAAGVKQMLEDVQERLVYRTHIYIQTDITGYKPAPGDLAYPDKLVMMEQIAQSLKDEQKKVPSEASFSDVHLEEGESNSLTKSGSTESLNPRPQTTISPADLHGMWYPTVRRTLVCLSKLYRCIDRAVFQGLSQEALSACIQSLLGASESISKNKTQIDGQLFLIKHLLILREQIAPFHTEFTIKEISLDLKKTRDAAFKILNPMTVPRFFRLNSNNALIEFLLEGTPEIREHYLDSKKDVDRHLKSACEQFIQQQTKLFVEQLEEFMTKVSALKTMASQGGPKYTLSQQPWAQPAKVNDLAATAYKTIKTKLPVTLRSMSLYLSNKDTEFILFKPVRNNIQQVFQKFHALLKEEFSPEDIQIIACPSMEQLSLLLLVSK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAEAALLLL ------CHHHHHHHC | 18.35 | 22814378 | |
| 21 | Ubiquitination | AERDAREKLALWDRR HCCHHHHHHHHCCCC | 33.24 | 29967540 | |
| 42 | Phosphorylation | LTDRQTDSVLELKAA CCCCCCCCHHHHHHH | 31.80 | - | |
| 93 | O-linked_Glycosylation | DILLKGFTSLGMEEE HHHHHCHHHCCCCHH | 31.54 | 29237092 | |
| 125 | Phosphorylation | QMDQDEGTKYRQMRD HCCCCCCHHHHHHHH | 23.90 | 29449344 | |
| 126 | Acetylation | MDQDEGTKYRQMRDY CCCCCCHHHHHHHHH | 49.66 | 20167786 | |
| 212 | Phosphorylation | TINTKLNSPTLSVNS HHCCCCCCCCCCCCC | 29.69 | 27050516 | |
| 214 | Phosphorylation | NTKLNSPTLSVNSDG CCCCCCCCCCCCCCC | 31.33 | 27050516 | |
| 216 | Phosphorylation | KLNSPTLSVNSDGFI CCCCCCCCCCCCCCH | 23.02 | 21406692 | |
| 219 | Phosphorylation | SPTLSVNSDGFIPML CCCCCCCCCCCHHHH | 36.63 | 21406692 | |
| 273 | Phosphorylation | YTVNTLQTLTSQLLK CHHHHHHHHHHHHHH | 34.81 | - | |
| 424 | Ubiquitination | VIHLETLSELCGILK HHCHHHHHHHHHHHH | 35.62 | 24816145 | |
| 468 | O-linked_Glycosylation | QERLVYRTHIYIQTD HHHHHHEEEEEEEEC | 8.57 | 29237092 | |
| 477 | O-linked_Glycosylation | IYIQTDITGYKPAPG EEEEECCCCCCCCCC | 36.95 | 29237092 | |
| 511 | Phosphorylation | DEQKKVPSEASFSDV HHHHCCCCCCCCCCC | 49.10 | 21712546 | |
| 514 | Phosphorylation | KKVPSEASFSDVHLE HCCCCCCCCCCCCCC | 22.64 | 23401153 | |
| 516 | Phosphorylation | VPSEASFSDVHLEEG CCCCCCCCCCCCCCC | 35.91 | 26657352 | |
| 525 | Phosphorylation | VHLEEGESNSLTKSG CCCCCCCCCCCCCCC | 42.44 | 28450419 | |
| 527 | Phosphorylation | LEEGESNSLTKSGST CCCCCCCCCCCCCCC | 46.85 | 26074081 | |
| 529 | Phosphorylation | EGESNSLTKSGSTES CCCCCCCCCCCCCCC | 24.00 | 28450419 | |
| 531 | Phosphorylation | ESNSLTKSGSTESLN CCCCCCCCCCCCCCC | 32.51 | 29255136 | |
| 533 | Phosphorylation | NSLTKSGSTESLNPR CCCCCCCCCCCCCCC | 35.77 | 29255136 | |
| 534 | Phosphorylation | SLTKSGSTESLNPRP CCCCCCCCCCCCCCC | 32.87 | 29255136 | |
| 536 | Phosphorylation | TKSGSTESLNPRPQT CCCCCCCCCCCCCCC | 33.27 | 23927012 | |
| 543 | Phosphorylation | SLNPRPQTTISPADL CCCCCCCCCCCHHHH | 28.87 | 26657352 | |
| 544 | Phosphorylation | LNPRPQTTISPADLH CCCCCCCCCCHHHHC | 17.76 | 23927012 | |
| 546 | Phosphorylation | PRPQTTISPADLHGM CCCCCCCCHHHHCCC | 16.37 | 26657352 | |
| 557 | Phosphorylation | LHGMWYPTVRRTLVC HCCCCHHHHHHHHHH | 15.79 | 23927012 | |
| 604 | Phosphorylation | ESISKNKTQIDGQLF HHHCCCCCCCCHHHH | 39.90 | 21406692 | |
| 636 | Phosphorylation | EFTIKEISLDLKKTR EEEEEEECCCCHHHH | 19.54 | 27251275 | |
| 648 | Ubiquitination | KTRDAAFKILNPMTV HHHHHHHHHHCCCCC | 41.37 | 24816145 | |
| 654 | Phosphorylation | FKILNPMTVPRFFRL HHHHCCCCCCEEEEE | 28.72 | 23612710 | |
| 663 | Phosphorylation | PRFFRLNSNNALIEF CEEEEECCCCHHHHH | 35.73 | 28355574 | |
| 675 | Phosphorylation | IEFLLEGTPEIREHY HHHHHCCCHHHHHHH | 14.36 | 23532336 | |
| 694 | Ubiquitination | KDVDRHLKSACEQFI HHHHHHHHHHHHHHH | 29.86 | 29967540 | |
| 717 | Phosphorylation | EQLEEFMTKVSALKT HHHHHHHHHHHHHHH | 33.35 | - | |
| 723 | Ubiquitination | MTKVSALKTMASQGG HHHHHHHHHHHHCCC | 35.65 | 29967540 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of COG3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of COG3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of COG3_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
| "Exploring proteomes and analyzing protein processing by massspectrometric identification of sorted N-terminal peptides."; Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,Thomas G.R., Vandekerckhove J.; Nat. Biotechnol. 21:566-569(2003). Cited for: PROTEIN SEQUENCE OF 2-16, AND ACETYLATION AT ALA-2. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-663, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-533 AND SER-663, ANDMASS SPECTROMETRY. | |